Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Genomic Characterization Provides Diagnostic Clarity in Cases with Overlapping Bone Marrow Fibrosis and Monocytosis

Andrew T Kuykendall, MD, Chetasi Talati, MD, Ling Zhang, MD, Najla Al Ali, M.Sc, Kendra L. Sweet, MD, David A Sallman, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Eric Padron, MD, Rami S. Komrokji, MD

Blood (2018) 132 (Supplement 1): 4283.

https://doi.org/10.1182/blood-2018-99-117796

Published: 2018

Journal Articles

Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen

Haris Ali, MD, Ibrahim Aldoss, MD, Dongyun Yang, PhD, Michelle Afkhami, MD, Monzr M. Al Malki, MD, Thai Cao, MD, Stephen J. Forman, MD FACP, Guido Marcucci, MD, Matthew Mei, MD, Sally Mokhtari, PhD, Ryotaro Nakamura, MD, Margaret O'Donnell, MD, Raju Pillai, MD, Vinod Pullarkat, MD MRCP, Amandeep Salhotra, MD, Anthony S. Stein, MD, David S. Snyder, MD

Blood (2017) 130 (Supplement 1): 199.

https://doi.org/10.1182/blood.V130.Suppl_1.199.199

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation As a Treatment Modality for Type 1 Cryoglobulinemia in Monoclonal Gammopathy of Renal Significance

Zhen Wang, MD, Noa Biran, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, MD PhD, David H. Vesole, MD PhD, Joshua R. Richter, MD

Blood (2016) 128 (22): 5835.

https://doi.org/10.1182/blood.V128.22.5835.5835

Published: 2016

Journal Articles

Characterization of Cytogenetic Abnormalities in Myelofibrosis and Relationship to Clinical Outcome

Andrew Kuykendall, MD, Chetasi Talati, MD, Najla H Al Ali, Eric Padron, MD, David Sallman, MD, Jeffrey E. Lancet, MD, Kendra L. Sweet, MD, Alan F. List, Kenneth S. Zuckerman, MD, Rami S. Komrokji, MD

Blood (2016) 128 (22): 1937.

https://doi.org/10.1182/blood.V128.22.1937.1937

Published: 2016

Journal Articles

Whole Exome Sequencing Reveals Clonal Evolution of Myeloproliferative Neoplasms to Acute Myeloid Leukemia

Jelena D Milosevic Feenstra, PhD, Elisa Rumi, MD, Daniela Pietra, PhD, Andreas Schönegger, Christoph Bock, PhD, Mario Cazzola, MD, Robert Kralovics, PhD

Blood (2015) 126 (23): 1626.

https://doi.org/10.1182/blood.V126.23.1626.1626

Published: 2015

Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone Is Superior to Pomalidomide and Dexamethasone in Relapsed and Refractory Myeloma: Results of a Multicenter Randomized Phase II Study

Rachid Baz, MD, Thomas G. Martin, MD, Melissa Alsina, MD, Kenneth H. Shain, MD PhD, Hearn J. Cho, MD PhD, Jeffrey L Wolf, MD, Anuj Mahindra, MD, Ajai Chari, MD, Daniel M Sullivan, MD, Lisa A Nardelli, BS, CCRP, Kenneth Lau, BA, Xiuhua Zhao, Hui-Yi Lin, PhD, Sundar Jagannath, MD

Blood (2014) 124 (21): 303.

https://doi.org/10.1182/blood.V124.21.303.303

Published: 2014

Journal Articles

Molecular Characterization Of Myelofibrosis Patients With Cytopenia Treated With Pomalidomide: Results From The Mpnsg 01-09 Study

Frank Stegelmann, MD, Maximilian Laaths, MD, Andreas Reiter, MD, Edgar Jost, Martin Griesshammer, MD, PhD, Norbert Gattermann, MD, Holger Hebart, Cornelius F. Waller, MD, Philippe Schafhausen, MD, Uwe Platzbecker, MD, PhD, Andreas Hochhaus, MD, Walter Verbeek, MD, Igor W. Blau, MD, Carmen Blersch, Susanne Kuhn, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD

Blood (2013) 122 (21): 4064.

https://doi.org/10.1182/blood.V122.21.4064.4064

Published: 2013

Journal Articles

Peripheral Blood Karyotyping Is Superior To Bone Marrow and Identifies Most Frequent Structural Chromosomal Rearrangements In Myelofibrosis

Vesna Najfeld, PhD, Joseph Tripodi, MS, Marina Kremanskaya, MD, John Mascarenhas, MD, Ronald Hoffman, MD

Blood (2013) 122 (21): 3727.

https://doi.org/10.1182/blood.V122.21.3727.3727

Published: 2013

Journal Articles

Inactivation Of BANK1 By a Novel IGH -Associated Translocation and 5’ Hypermethylation In B-Cell Lymphomas

Kui Nie, PhD, Taotao Zhang, MD, PhD, Jiong Yan, MD, PhD, Leonardo Boiocchi, MD, Shuhua Cheng, PhD, Susan Mathew, PhD, Yifang Liu, MD, Amy Chadburn, M.D., Attilio Orazi, MD, Daniel M Knowles, MD, Yen-Chun Liu, MD, PHD, Wayne Tam, MD, PhD

Blood (2013) 122 (21): 2497.

https://doi.org/10.1182/blood.V122.21.2497.2497

Published: 2013

Journal Articles

Cytogenetic Profile Of Multiple Myeloma In The Inner City: Clinical Presentation and Survival

Adam Goldrich, MD, Anuja Kriplani, MD, Andriane Melanthiou, MPH, Daniel Fein, MS3, Elizabeth Helzner, PhD, Arvind Babu, PhD, Jason Gonsky, MD, PhD, Olcay Batuman, MD

Blood (2013) 122 (21): 5355.

https://doi.org/10.1182/blood.V122.21.5355.5355

Published: 2013

Journal Articles

Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia

Simon B. Zeichner, D.O., Sarah Alghamdi, M.D., Gina Elhammady, M.D., Robert Poppiti, M.D., Amilcar Castellano-Sanchez, MD

Blood (2013) 122 (21): 4971.

https://doi.org/10.1182/blood.V122.21.4971.4971

Published: 2013

Journal Articles

Polycythemia Vera: Redefinition in the Genomic Era

Alison R. Moliterno, MD, Donna M. Williams, PhD, Michael A McDevitt, MD, PhD, Brady L Stein, MD, Jonathan M. Gerber, MD, Ophelia Rogers, Michael B. Streiff, MD, Sophie Lanzkron, M.D., Linda Resar, M.D., Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jerry L. Spivak, MD

Blood (2012) 120 (21): 1754.

https://doi.org/10.1182/blood.V120.21.1754.1754

Published: 2012

Journal Articles

Carfilzomib Combined with Thalidomide and Dexamethasone (CARTHADEX) As Induction Treatment Prior to High-Dose Melphalan (HDM) in Newly Diagnosed Patients with Multiple Myeloma (MM). A Trial of the European Myeloma Network EMN

Pieter Sonneveld, MD, PhD, Emilie Hacker, Sonja Zweegman, MD PhD, Marie Jose Kersten, MD, PhD, Edo Vellenga, PhD, Marinus van Marwijk-Kooy, MD, Okke de Weerdt, MD, Sarah Lonergan, MSc, Antonio Palumbo, MD, Henk M. Lokhorst, MD

Blood (2011) 118 (21): 633.

https://doi.org/10.1182/blood.V118.21.633.633

Published: 2011

Journal Articles

Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML

Panagiotis Kottaridis, MD, PhD, Maria Tsirogianni, MD, Janet North, BSc, MSc, Chloe Marden, PhD, Stephen Mackinnon, MD, Mark W Lowdell, PhD, FRCPath

Blood (2011) 118 (21): 946.

https://doi.org/10.1182/blood.V118.21.946.946

Published: 2011

Journal Articles

Coexistance of Multiple Myeloma and Myelodysplastic Syndrome or Lymphoid Diseases At Diagnosis: Evidence for Two Clonal and Independent Chromose Abnormalities

Hossein Mossafa, PhD, Sabine Defasque, Jr., MD, Christine Fourcade, Sr., JeanPierre Hurst, Sr., Bertrand Joly

Blood (2011) 118 (21): 5063.

https://doi.org/10.1182/blood.V118.21.5063.5063

Published: 2011

Journal Articles

Molecular Analysis of RAS-RAF Tyrosine-Kinase Signaling Pathway Alterations in Multiple Myeloma

Valentina Artusi, MSc, Claudia Haferlach, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Vera Grossmann, MSc

Blood (2011) 118 (21): 2876.

https://doi.org/10.1182/blood.V118.21.2876.2876

Published: 2011

Journal Articles

T Cells of Patients with Myelodysplastic Syndrome Are Frequently Derived From the Malignant Clone

Suzanne Vercauteren, MD, PhD, Daniel T. Starczynowski, PhD, Sandy Sung, Kelly McNeil, Chris Salski, Clara-Lynn Jensen, Helene Bruyere, MD, FCCMG, Wan Lam, Aly Karsan, MD, FRCPC

Blood (2011) 118 (21): 2808.

https://doi.org/10.1182/blood.V118.21.2808.2808

Published: 2011

Journal Articles

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Monique A Hartley, MD, Ling Zhang, MD, William Bulkeley, III, MD, Bijal D. Shah, MD, Sara Tinsley, ARNP, Javier Pinilla-Ibarz, MD

Blood (2010) 116 (21): 1224.

https://doi.org/10.1182/blood.V116.21.1224.1224

Published: 2010

Journal Articles

Occurrence of Chromosomal Abnormalities In Bone Marrow CD14 + monocytes of Multiple Myeloma Patients

Hana Svachova, Henrieta Greslikova, Aneta Mikulasova, Kristina Berankova, Pavel Nemec, Jiri Mayer, MD, PhD, Roman Hajek

Blood (2010) 116 (21): 2968.

https://doi.org/10.1182/blood.V116.21.2968.2968

Published: 2010

Journal Articles

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Rita Coutinho, MD, Dolors Costa, PhD, Ana Carrió, PhD, Ana Vidal, BS, Mohammed Belkaid, MS, Elias Campo, MD, PhD, Emili Montserrat, MD, PhD, Benet Nomdedeu, MD

Blood (2009) 114 (22): 1746.

https://doi.org/10.1182/blood.V114.22.1746.1746

Published: 2009

NARROW

Genomic Characterization Provides Diagnostic Clarity in Cases with Overlapping Bone Marrow Fibrosis and Monocytosis

Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen

Autologous Stem Cell Transplantation As a Treatment Modality for Type 1 Cryoglobulinemia in Monoclonal Gammopathy of Renal Significance

Characterization of Cytogenetic Abnormalities in Myelofibrosis and Relationship to Clinical Outcome

Whole Exome Sequencing Reveals Clonal Evolution of Myeloproliferative Neoplasms to Acute Myeloid Leukemia

Pomalidomide, Cyclophosphamide, and Dexamethasone Is Superior to Pomalidomide and Dexamethasone in Relapsed and Refractory Myeloma: Results of a Multicenter Randomized Phase II Study

Molecular Characterization Of Myelofibrosis Patients With Cytopenia Treated With Pomalidomide: Results From The Mpnsg 01-09 Study

Peripheral Blood Karyotyping Is Superior To Bone Marrow and Identifies Most Frequent Structural Chromosomal Rearrangements In Myelofibrosis

Inactivation Of BANK1 By a Novel IGH -Associated Translocation and 5’ Hypermethylation In B-Cell Lymphomas

Cytogenetic Profile Of Multiple Myeloma In The Inner City: Clinical Presentation and Survival

Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia

Polycythemia Vera: Redefinition in the Genomic Era

Carfilzomib Combined with Thalidomide and Dexamethasone (CARTHADEX) As Induction Treatment Prior to High-Dose Melphalan (HDM) in Newly Diagnosed Patients with Multiple Myeloma (MM). A Trial of the European Myeloma Network EMN

Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML

Coexistance of Multiple Myeloma and Myelodysplastic Syndrome or Lymphoid Diseases At Diagnosis: Evidence for Two Clonal and Independent Chromose Abnormalities

Molecular Analysis of RAS-RAF Tyrosine-Kinase Signaling Pathway Alterations in Multiple Myeloma

T Cells of Patients with Myelodysplastic Syndrome Are Frequently Derived From the Malignant Clone

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Occurrence of Chromosomal Abnormalities In Bone Marrow CD14 + monocytes of Multiple Myeloma Patients

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only